1. Home
  2. CODA vs VIGL Comparison

CODA vs VIGL Comparison

Compare CODA & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODA
  • VIGL
  • Stock Information
  • Founded
  • CODA 1994
  • VIGL 2020
  • Country
  • CODA United States
  • VIGL United States
  • Employees
  • CODA N/A
  • VIGL N/A
  • Industry
  • CODA Industrial Machinery/Components
  • VIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CODA Industrials
  • VIGL Health Care
  • Exchange
  • CODA Nasdaq
  • VIGL Nasdaq
  • Market Cap
  • CODA 92.5M
  • VIGL 89.3M
  • IPO Year
  • CODA N/A
  • VIGL 2022
  • Fundamental
  • Price
  • CODA $7.99
  • VIGL $2.71
  • Analyst Decision
  • CODA Strong Buy
  • VIGL Strong Buy
  • Analyst Count
  • CODA 1
  • VIGL 5
  • Target Price
  • CODA $11.00
  • VIGL $21.00
  • AVG Volume (30 Days)
  • CODA 30.6K
  • VIGL 2.7M
  • Earning Date
  • CODA 03-17-2025
  • VIGL 03-25-2025
  • Dividend Yield
  • CODA N/A
  • VIGL N/A
  • EPS Growth
  • CODA 14.29
  • VIGL N/A
  • EPS
  • CODA 0.32
  • VIGL N/A
  • Revenue
  • CODA $20,316,161.00
  • VIGL N/A
  • Revenue This Year
  • CODA $31.72
  • VIGL N/A
  • Revenue Next Year
  • CODA $12.23
  • VIGL N/A
  • P/E Ratio
  • CODA $25.09
  • VIGL N/A
  • Revenue Growth
  • CODA 4.98
  • VIGL N/A
  • 52 Week Low
  • CODA $5.48
  • VIGL $1.49
  • 52 Week High
  • CODA $9.89
  • VIGL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • CODA 46.65
  • VIGL 68.53
  • Support Level
  • CODA $7.75
  • VIGL $2.55
  • Resistance Level
  • CODA $8.58
  • VIGL $2.88
  • Average True Range (ATR)
  • CODA 0.32
  • VIGL 0.23
  • MACD
  • CODA 0.00
  • VIGL 0.04
  • Stochastic Oscillator
  • CODA 28.92
  • VIGL 80.23

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.

Share on Social Networks: